Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

What Were the Top-line Data Results from the LEAP-1 Study?

OCT 06, 2017 | CONTAGION® EDITORIAL STAFF


Steven Gelone, PharmD, chief scientific officer at Nabriva Therapeutics, shares the topline data yielded from the LEAP-1 study.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.